Employees Retirement System of Texas Continues to Hold Stake in Bruker Corporation (BRKR)
Employees Retirement System of Texas held its position in shares of Bruker Corporation (NASDAQ:BRKR) during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 84,000 shares of the medical research company’s stock at the close of the second quarter. Employees Retirement System of Texas owned about 0.05% of Bruker Corporation worth $2,423,000 as of its most recent SEC filing.
A number of other institutional investors and hedge funds have also added to or reduced their stakes in the business. Tudor Investment Corp ET AL raised its position in Bruker Corporation by 1.5% in the second quarter. Tudor Investment Corp ET AL now owns 15,980 shares of the medical research company’s stock worth $461,000 after acquiring an additional 242 shares during the period. PDT Partners LLC bought a new position in Bruker Corporation in the second quarter worth approximately $6,746,000. Balyasny Asset Management LLC raised its position in Bruker Corporation by 237.3% in the second quarter. Balyasny Asset Management LLC now owns 55,457 shares of the medical research company’s stock worth $1,599,000 after acquiring an additional 39,015 shares during the period. Stifel Financial Corp bought a new position in Bruker Corporation in the second quarter worth approximately $575,000. Finally, Bayesian Capital Management LP bought a new position in Bruker Corporation in the second quarter worth approximately $430,000. Institutional investors and hedge funds own 65.42% of the company’s stock.
Shares of Bruker Corporation (NASDAQ BRKR) opened at 30.11 on Wednesday. The company has a market capitalization of $4.78 billion, a P/E ratio of 30.02 and a beta of 1.09. The stock’s 50 day moving average is $29.47 and its 200 day moving average is $27.26. Bruker Corporation has a 12 month low of $19.59 and a 12 month high of $30.69.
Bruker Corporation (NASDAQ:BRKR) last announced its quarterly earnings results on Thursday, August 3rd. The medical research company reported $0.23 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.20 by $0.03. Bruker Corporation had a net margin of 9.65% and a return on equity of 26.66%. The firm had revenue of $414.90 million for the quarter, compared to the consensus estimate of $384.75 million. During the same period in the prior year, the firm posted $0.20 earnings per share. The firm’s quarterly revenue was up 11.6% compared to the same quarter last year. On average, equities analysts predict that Bruker Corporation will post $1.12 EPS for the current fiscal year.
The company also recently declared a quarterly dividend, which was paid on Friday, September 22nd. Investors of record on Tuesday, September 5th were issued a dividend of $0.04 per share. This represents a $0.16 dividend on an annualized basis and a yield of 0.53%. The ex-dividend date of this dividend was Thursday, August 31st. Bruker Corporation’s dividend payout ratio (DPR) is presently 16.00%.
Several research firms have weighed in on BRKR. Goldman Sachs Group, Inc. (The) reiterated a “sell” rating and issued a $24.00 price target on shares of Bruker Corporation in a research report on Tuesday, September 26th. Zacks Investment Research upgraded shares of Bruker Corporation from a “hold” rating to a “buy” rating and set a $33.00 price target on the stock in a research report on Thursday, July 6th. Barclays PLC reiterated an “equal weight” rating and issued a $30.00 price target (up from $26.00) on shares of Bruker Corporation in a research report on Monday, July 17th. Wells Fargo & Company downgraded shares of Bruker Corporation from a “market perform” rating to an “underperform” rating in a research report on Wednesday, July 12th. Finally, Cowen and Company reiterated a “hold” rating and issued a $29.00 price target on shares of Bruker Corporation in a research report on Friday, July 14th. Two investment analysts have rated the stock with a sell rating, eight have issued a hold rating and five have assigned a buy rating to the stock. Bruker Corporation has an average rating of “Hold” and a consensus price target of $26.70.
TRADEMARK VIOLATION WARNING: This piece was first posted by The Cerbat Gem and is the property of of The Cerbat Gem. If you are viewing this piece on another publication, it was illegally stolen and reposted in violation of U.S. and international copyright & trademark legislation. The original version of this piece can be viewed at https://www.thecerbatgem.com/2017/10/11/employees-retirement-system-of-texas-continues-to-hold-stake-in-bruker-corporation-brkr.html.
In related news, VP Mark Munch sold 21,061 shares of the stock in a transaction on Wednesday, September 13th. The shares were sold at an average price of $29.97, for a total transaction of $631,198.17. Following the sale, the vice president now directly owns 60,524 shares of the company’s stock, valued at $1,813,904.28. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Frank H. Laukien purchased 2,335 shares of the stock in a transaction that occurred on Thursday, August 10th. The shares were purchased at an average cost of $27.39 per share, for a total transaction of $63,955.65. Following the completion of the acquisition, the chief executive officer now directly owns 37,791,386 shares of the company’s stock, valued at approximately $1,035,106,062.54. The disclosure for this purchase can be found here. Corporate insiders own 35.20% of the company’s stock.
Bruker Corporation Company Profile
Bruker Corporation designs and manufactures scientific instruments, and analytical and diagnostic solutions. Its segments include the Bruker BioSpin Group; the Bruker Chemicals, Applied Markets, Life Science, In-Vitro Diagnostics, Detection (CALID) Group; the Bruker Nano Group, and the Bruker Energy & Supercon Technologies (BEST) Segment.
Want to see what other hedge funds are holding BRKR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Bruker Corporation (NASDAQ:BRKR).
Receive News & Stock Ratings for Bruker Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bruker Corporation and related stocks with our FREE daily email newsletter.